Sitrin Capital Management LLC Charles River Laboratories International, Inc. Transaction History

Sitrin Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$204.13 - $302.4 $3.93 Million - $5.82 Million	-19,255 Closed	0 $0
Q1 2022 Apr 19, 2022	BUY	$255.51 - $362.11 $2,044 - $2,896	8 Added 0.04%	19,255 $5.47 Million
Q4 2021 Jan 18, 2022	BUY	$351.38 - $448.68 $9,838 - $12,563	28 Added 0.15%	19,247 $7.25 Million
Q3 2021 Nov 05, 2021	SELL	$372.64 - $458.3 $14,905 - $18,332	-40 Reduced 0.21%	19,219 $7.93 Million
Q2 2021 Jul 22, 2021	SELL	$294.17 - $371.65 $2.26 Million - $2.85 Million	-7,674 Reduced 28.49%	19,259 $7.12 Million
Q1 2021 Apr 29, 2021	SELL	$249.67 - $299.48 $28,212 - $33,841	-113 Reduced 0.42%	26,933 $7.81 Million
Q4 2020 Feb 02, 2021	BUY	$222.0 - $252.62 $58,608 - $66,691	264 Added 0.99%	27,046 $6.76 Million
Q3 2020 Oct 23, 2020	BUY	$175.56 - $226.45 $4.7 Million - $6.06 Million	26,782 New	26,782 $6.13 Million

694

52.2M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.29B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Sitrin Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Sitrin Capital Management LLC with notifications on news.